Daiichi Sankyo PT is a renowned brand that has a rich history spanning over 100 years. It was established in 2005 through the merger of Daiichi Pharmaceutical and Sankyo. With a mission to innovate in the pharmaceutical industry, Daiichi Sankyo offers a wide range of products and services.

Their product portfolio includes breakthrough medications such as antiplatelet agents, therapeutic agents for diabetes, anti-influenza virus agents, oral FXa inhibitors, proton pump inhibitors, and more. Notable contributions include the launch of Prasugrel, a global antiplatelet agent, and edoxaban, an oral anti-coagulant. Daiichi Sankyo is committed to improving healthcare and quality of life through continuous research and development.

They have expanded their operations globally, with subsidiaries and partnerships in various countries. The brand's dedication to innovation, quality, and patient care has made them a leader in the pharmaceutical industry